According to a BMC’s Sero Survey done by the Brihanmumbai Municipal Corporation, 50% of children in Mumbai’s healthcare settings had Covid antibodies.
BMC’s Sero Survey: In May and June, a study of children aged 6 to 18 was performed in 24 Mumbai wards.
The Sero survey data might help prepare for a third wave that will likely hit the state in the following weeks or months.
The BMC’s Sero Survey included a ten thousand kid sample.
BYL Nair Hospital and BMC’s Kasturba Molecular Diagnostic Laboratory performed a serosurvey of SARS-CoV-2 infection among Mumbai’s children population “owing to the impending risk of the third wave to the pediatric population.”
According to the BMC’s Sero Survey, antibodies to COVID-19 were detected in more than half of the pediatric population in healthcare settings. Furthermore, the number of children with antibodies has grown since the previous serosurvey, according to a BMC press statement.
“According to the findings of this investigation, more than half of the pediatric population in a hospital environment has been exposed to SARS-COV-2. According to the survey results, total seropositivity is 51.18 percent, with 54.36 percent from the public sector and 47.03 percent from the private sector.
According to the statement, seropositivity is highest in the age bracket of 10-14 years, with 53.43 percent.
“Taking age into account, the Seropositivity rate for children aged 1 to 4 years is 51.04 percent, for children aged 5 to 9 years it is 47.33 percent, for children aged 10 to 14 years it is 53.43 percent, and for children aged 15 to 18 years, it is 51.39 percent. Thus, the total Seropositivity rate among children aged 1 to 18 years is 51.18 percent, according to the BMC.
According to BMC, children’s seropositivity has increased in this research compared to a prior one in March 2021. “The most recent survey revealed a seropositivity rate of 39.4% in the 18-year-old age group, indicating that a large number of minors using healthcare facilities were exposed to the virus during the second wave of COVID-19,” it added.